Filing Details

Accession Number:
0001209191-12-033474
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-06-12 17:29:02
Reporting Period:
2012-06-08
Filing Date:
2012-06-12
Accepted Time:
2012-06-12 16:29:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1009356 Salix Pharmaceuticals Ltd SLXP Pharmaceutical Preparations (2834) 943267443
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1212667 Thomas Alonzo D 8510 Colonnade Center Drive
Raleigh NC 27615
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-06-08 7,000 $51.63 75,640 No 4 S Direct
Common Stock Disposition 2012-06-08 2,550 $51.63 0 No 4 S Indirect By LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect By LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,080 Indirect By Trust
Common Stock 260 Indirect By LP
Common Stock 6,500 Indirect By Wife
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Option to Buy Common Stock $17.63 2015-06-09 15,000 15,000 Direct
Common Stock Option to Buy Common Stock $18.87 2014-06-17 22,500 22,500 Direct
Common Stock Option to Buy Common Stock $7.60 2013-07-24 15,000 15,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2015-06-09 15,000 15,000 Direct
2014-06-17 22,500 22,500 Direct
2013-07-24 15,000 15,000 Direct
Footnotes
  1. The shares are held by the Rachel L. D'Alonzo Rev Trust U/A DTD 10/24/2001 for which the Reporting Person serves as co-trustee.
  2. Options are 100% vested.